Amgen Ventures
Thousand Oaks, California, United StatesFounded 2004
Amgen Ventures is the corporate venture capital arm of Amgen, a global biotechnology company. It invests in emerging biotechnology companies to advance promising new medicines and technologies across oncology, inflammation, cardiovascular, neuroscience, and metabolic disorders.
39% of their portfolio is in Biotech & Life Sciences. They made 5 investments in the last 12 months. Average disclosed round size is $68.0M (across 88 rounds with reported amounts).
Portfolio
69
Fund Size
—
Top Stage
Series B
Last 12 Mo
5
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
100 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| BBigHat | Series C | $75M | Sep 2026 |
 Ember LifeSciences | Series A | $16.5M | Dec 2025 |
 Ember LifeSciences | Series A | $16.5M | Dec 2025 |
 AAVantgarde Bio | Series B | — | Nov 2025 |
 Cartography | Series B | $67M | Oct 2025 |
| IImago | Series B | $1.4M | Jan 2025 |
 Mindset Medical | Series A | — | Jun 2024 |
 Enlaza Therapeutics | Series A | $100M | Apr 2024 |
 Ember | Series A | $27M | Mar 2024 |
 Vigil Neuroscience | Series A | $50M | Jan 2024 |
 BioAge | Series D | $300M | Jan 2024 |
 Seismic | Series B | $121M | Dec 2023 |
 Tiledb Inc | Series B | $34M | Oct 2023 |
 Generate:Biomedicines | Series C | $273M | Sep 2023 |
 Seismic Therapeutic | Series B | $121M | Jan 2023 |
 Inversago Pharma | Series C | — | Jan 2023 |
 Kernal Biologics | Series A | $25M | Jul 2022 |
| CCelsius Therapeutics | Series A | $63M | Mar 2022 |
| CCelsius Therapeutics | Series B | $83M | Mar 2022 |
 Gandeeva Therapeutics | Series A | $40M | Jan 2022 |
 BigHat Biosciences | Series B | $75M | Jan 2022 |
| CCasma Therapeutics | Series C | $46M | Jan 2022 |
 Obsidian Therapeutics | Series B | $115M | Sep 2021 |
| AAkili, Inc. | Series D | $110.0M | May 2021 |
 Hummingbird Bioscience | Series C | $125M | May 2021 |
Page 1 of 4
Top Co-Investors
Alexandria Venture Investments17 shared
Atlas Venture14 shared
Alta Partners13 shared
Samsara BioCapital12 shared
Celgene12 shared
Roche Venture Fund10 shared
New Enterprise Associates9 shared
Polaris Partners9 shared
Sanofi Ventures8 shared
GV8 shared
Surveyor Capital8 shared
Pfizer Ventures8 shared
Frazier Healthcare Partners8 shared
Mirae Asset7 shared
SV Health Investors7 shared
Astellas Venture Management7 shared
Novartis Venture Fund6 shared
Tekla Capital Management6 shared
MPM Capital6 shared
Fountain Healthcare Partners6 shared
Last updated: 20 October 2026